| scholarly article | Q13442814 |
| P2093 | author name string | P James | |
| K Ogiwara | |||
| D Lillicrap | |||
| A Michels | |||
| J Grabell | |||
| W Hopman | |||
| S Albánez | |||
| P2860 | cites work | The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms | Q45730907 |
| Plasma von Willebrand factor and arterial aging | Q46447114 | ||
| Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma | Q50237767 | ||
| No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance. | Q53619865 | ||
| von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis | Q59242720 | ||
| Relation of the Prothrombotic State to Increasing Age (from the Framingham Offspring Study) | Q59608032 | ||
| The effect of exercise on von Willebrand factor and ADAMTS-13 in individuals with type 1 and type 2B von Willebrand disease | Q59679399 | ||
| Human Umbilical Vein Endothelial Cells Differ from Other Endothelial Cells in Failing to Express ABO Blood Group Antigens | Q60034609 | ||
| von Willebrand disease and aging: an evolving phenotype | Q62107242 | ||
| Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle-aged asymptomatic subjects | Q62693846 | ||
| Comparative study of the sugar chains of factor VIII purified from human plasma and from the culture media of recombinant baby hamster kidney cells | Q68101165 | ||
| Human plasma alpha 2-macroglobulin and von Willebrand factor possess covalently linked ABO(H) blood group antigens in subjects with corresponding ABO phenotype | Q72087210 | ||
| von Willebrand factor and its propeptide in children with diabetes. Relation between endothelial dysfunction and microalbuminuria | Q73023597 | ||
| Von Willebrand factor propeptide in vascular disorders | Q74314907 | ||
| Von Willebrand factor in Italian centenarians | Q78846136 | ||
| ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens | Q80059284 | ||
| Von Willebrand disease | Q80994281 | ||
| Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma | Q81041403 | ||
| Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis | Q82279339 | ||
| Possible role of ABO system in age-related diseases and longevity: a narrative review | Q21093222 | ||
| Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study | Q28743878 | ||
| Hemostasis factors and aging | Q33299066 | ||
| von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation | Q33329307 | ||
| Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome | Q33393270 | ||
| Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases | Q33398134 | ||
| Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium | Q33817075 | ||
| Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels | Q34113248 | ||
| The effect of ABO blood group on the diagnosis of von Willebrand disease. | Q34180946 | ||
| Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. | Q35848737 | ||
| ABO Blood Groups and Cardiovascular Diseases | Q36361023 | ||
| Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease | Q36369902 | ||
| von Willebrand factor, endothelial dysfunction, and cardiovascular disease | Q36481209 | ||
| Hemostasis and aging | Q36543985 | ||
| ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? | Q36604393 | ||
| Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD). | Q36658007 | ||
| ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. | Q36987171 | ||
| von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. | Q37112364 | ||
| Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study | Q37353655 | ||
| von Willebrand factor to the rescue. | Q37422872 | ||
| Evolutionary aspects of ABO blood group in humans | Q38358460 | ||
| von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends | Q38364984 | ||
| Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke | Q39426411 | ||
| Relation of ABO blood groups to the severity of coronary atherosclerosis: an Gensini score assessment. | Q41739487 | ||
| Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures | Q41906702 | ||
| A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor | Q42524319 | ||
| VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease | Q42937413 | ||
| Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series | Q43123377 | ||
| Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents | Q43138945 | ||
| Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites | Q43153106 | ||
| Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis | Q43701770 | ||
| Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans | Q44638884 | ||
| Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease | Q45145414 | ||
| Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals | Q45192189 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 953-963 | |
| P577 | publication date | 2016-04-27 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. | |
| P478 | volume | 14 |
| Q57456624 | A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding |
| Q92657008 | ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology |
| Q104610460 | Acquired von Willebrand syndrome and factor VIII in patients with moderate to severe mitral regurgitation undergoing transcatheter mitral valve repair |
| Q64240724 | Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor |
| Q92983714 | Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms |
| Q45874634 | Can you grow out of von Willebrand disease? |
| Q55617050 | Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease. |
| Q38690381 | Controversies in the diagnosis of Type 1 von Willebrand disease |
| Q33608224 | Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders |
| Q38814362 | Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24. |
| Q38822601 | Elucidation of Factor VIII Activity Pharmacokinetics: A Pooled Population Analysis in Patients With Hemophilia A Treated With Moroctocog Alfa |
| Q33435117 | Histones link inflammation and thrombosis through the induction of Weibel-Palade body exocytosis |
| Q89774833 | Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia A |
| Q37733182 | Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population. |
| Q99566288 | Intronic regions of the human coagulation factor VIII gene harboring transcription factor binding sites with a strong bias towards the short-interspersed elements |
| Q97551370 | Low VWF: insights into pathogenesis, diagnosis, and clinical management |
| Q48719553 | New insights into the non-hemostatic role of von Willebrand factor in endothelial protection |
| Q33436573 | PT-VWD posing diagnostic and therapeutic challenges - small case series. |
| Q90441308 | Physiological Roles of the von Willebrand Factor-Factor VIII Interaction |
| Q49246959 | Regulation of plasma von Willebrand factor. |
| Q89800067 | Significant decrease of von Willebrand factor and plasminogen activator inhibitor-1 by providing supplementation with selenium and coenzyme Q10 to an elderly population with a low selenium status |
| Q59511557 | The common single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance |
| Q89691100 | The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease |
| Q58781583 | Von Willebrand disease in the elderly: clinical perspectives |
| Q30240214 | What have we learned from large population studies of von Willebrand disease? |
Search more.